Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 4/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23365026 | 1.00 | TSHR (0.47) | TSHRTHRBNAAACES2EPHX1 | |
| SCHEMBL23365060 | 1.00 | TSHR (0.47) | TSHRTHRBNAAACES2EPHX1 | |
| SCHEMBL17965931 | 0.97 | NAAA (0.42) | TSHRTHRBNAAACES2EPHX1 | |
| SCHEMBL28200062 | 0.89 | NAAA (0.38) | TSHRTHRBNAAACES2EPHX1 | |
| SCHEMBL339180 | 0.88 | ADRB2 (0.45) | TSHRTHRBNAAACES2CA1 | |
| Hydrochloric Acid SCHEMBL9709358 | 0.85 | ADRB2 (0.43) | TSHRTHRBNAAACES2CA1 | |
| SCHEMBL21812049 | 0.82 | ADRB2 (0.41) | TSHRTHRBNAAACES2CA1 | |
| SCHEMBL5057904 | 0.81 | NAAA (0.38) | TSHRTHRBNAAACES2EPHX1 | |
| SCHEMBL28664108 | 0.80 | THRB (0.44) | TSHRTHRBNAAACES2MEN1 | |
| SCHEMBL29287880 | 0.80 | THRB (0.44) | TSHRTHRBNAAACES2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024122620-A1 | EYEGLASS LENS | ホヤ レンズ タイランド リミテッド | 2024-06-13 | — | — | WO | disclosed |
| CN-118043728-A | Spectacle lens, stain-proofing agent composition, and method for producing spectacle lens | 豪雅镜片泰国有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-118043729-A | Spectacle lens, stain-proofing agent composition, and method for producing spectacle lens | 豪雅镜片泰国有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023054433-A1 | EYEGLASS LENS, ANTIFOULING AGENT COMPOSITION, AND METHOD FOR MANUFACTURING EYEGLASS LENS | ホヤ レンズ タイランド リミテッド | 2023-04-06 | — | — | WO | disclosed |
| WO-2023054434-A1 | LENS FOR EYEWEAR, ANTIFOULING AGENT COMPOSITION, AND METHOD FOR PRODUCING LENS FOR EYEWEAR | ホヤ レンズ タイランド リミテッド | 2023-04-06 | — | — | WO | disclosed |
| US-20220403056-A1 | CURED RUBBER NETWORK WITH COVALENT AND HYDROGEN-BONDED CROSSLINKS | BRIDGESTONE CORPORATION (JP) | 2022-12-22 | — | — | US | disclosed |
| EP-4058487-A2 | CURED RUBBER NETWORK WITH COVALENT AND HYDROGEN-BONDED CROSSLINKS | BRIDGESTONE CORPORATION (JP) | 2022-09-21 | — | — | EP | disclosed |
| WO-2021097455-A2 | CURED RUBBER NETWORK WITH COVALENT AND HYDROGEN-BONDED CROSSLINKS | BRIDGESTONE CORPORATION (JP) | 2021-05-20 | — | — | WO | disclosed |
| US-20090036687-A1 | MULTINUCLEAR COMPLEX AND CONDENSATION PRODUCT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036687-A1 | MULTINUCLEAR COMPLEX AND CONDENSATION PRODUCT THEREOF | MNS1, PICALM, NCAPD2 | TSHR 3776/4885THRB 4338/4885NAAA 4149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.